Among these alpha-1 antitrypsin (A1AT) was identified as a critical effector of mutp53 in driving lung cancer invasion in vitro and in vivo, and correlated with adverse prognosis in mutp53-expressing lung adenocarcinoma patients [76]. Here, SERPINA1 is linked to lung adenocarcinoma.